Limbic Raises $14M to Bring Clinical Mental Health AI to U.S. Providers
Limbic offers a clinical mental health care companion, utilizing a chatbot interface powered by a clinical AI brain.
Company Name: Limbic
Location: NYC, USA, and London, UK
Sector: Clinical Mental Health AI Technology
Funding Details: Raised $14M in funding. The round was led by Khosla Ventures, with participation from Gaingels and Illusian.
Purpose of Investment: To expand the availability of its clinical mental health AI to U.S. health providers.
Leadership: Dr. Ross Harper, CEO
Product: Limbic offers a clinical mental health care companion, utilizing a chatbot interface powered by a clinical AI brain. This tool guides patients through 100 themed activities and educational materials, aiming to provide mental health support with clinical rigor on an on-demand basis.
Impact: Limbic claims significant achievements in the NHS, including helping over 260,000 patients enter care, releasing over 50,000 clinical hours for NHS services, and generating economic savings. It also claims to have contributed to increasing the diversity of patients accessing mental health care.
About: Limbic is integrating artificial intelligence with clinical mental health practices. The company specializes in developing AI-powered solutions aimed at enhancing mental health care provision. By employing a chatbot interface equipped with a sophisticated clinical AI brain, Limbic creates a virtual care companion that offers patients personalized mental health support outside of traditional therapy sessions. This approach facilitates access to therapeutic activities and educational materials, ensuring users receive consistent support tailored to their needs.
